The activity of aripiprazole is presumed to be primarily due to the parent drug and less to its metabolite, dehydroaripiprazole, which has an affinity for D 2-receptors similar to that of ...
On March 13, 2020, the Ontario Superior Court of Justice certified a national class action on behalf of ABILIFY® and ABILIFY MAINTENA® Class Members relating to the Defendant drug manufacturers' ...
A drug-device combination, Abilify MyCite was approved by the US regulator for schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder, and as an add-on ...
Aripiprazole is a second-generation antipsychotic that is used to treat manic and mixed episodes associated with bipolar disorder. Like lurasidone, it can be used alone or with other medications. You ...
Recently, second-generation antipsychotics (SGAs), olanzapine plus fluoxetine, quetiapine extended release and aripiprazole have clearly demonstrated efficacy in the treatment of MDD patients ...
These alterations make it harder for people to stop using substances even when they want to, which can lead to drug addiction. It is possible to overcome drug addiction, but it takes commitment and ...
Bristol-Myers Squibb Company ( NYSE: BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference November 11, 2024 10:00 AM ET Samit Hirawat - EVP, Chief Medical Officer, Global Drug ...
Abilify Mycite did the opposite of that ... current focus on a limited range of health problems, chiefly cancer. The drug industry has pivoted towards this because of the money available for ...
Drug safety relates to the potential for adverse effects related to the administration of drugs. Efforts to establish the safely profile of drugs begin early in their development, with in vitro ...